Evidence map›Paper›PMID 34222130›Full record

ArticleClinical and experimental vaccine research2021

Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country.

Abdel-Hameed Al-Mistarehi, Khalid A Kheirallah, Ahmed Yassin, Safwan Alomari, Maryam K Aledrisi, Ehab M Bani Ata, Nouran H Hammad, Asim N Khanfar, Ali M Ibnian, Basheer Y Khassawneh

Open access · diamondAbstract read
In one paragraph

Article in Clinical and experimental vaccine research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 4 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 4 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Exploring the experience of developing COVID-19 vaccines in Iran.Clinical and experimental vaccine research · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Abdel-Hameed Al-MistarehiDepartment of Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0003-4713-8536
Khalid A KheirallahDepartment of Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0003-4504-4472
Ahmed YassinDivision of Neurology, Department of Neurosciences, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0002-3175-0408
Safwan AlomariJohns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID https://orcid.org/0000-0001-7368-0404
Maryam K AledrisiDepartment of Obstetrics and Gynecology, King Saud Medical City (KSMC), Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-9359-3516
Ehab M Bani AtaDepartment of Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0002-8453-7061
Nouran H HammadFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0002-5468-7472
Asim N KhanfarFaculty of Medicine, University of Jordan, Amman, Jordan.ORCID https://orcid.org/0000-0002-4754-9872
Ali M IbnianDepartment of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0002-5933-9426
Basheer Y KhassawnehDepartment of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0003-2160-4498
Jordan University of Science and Technology · JOJohns Hopkins University · USKing Saud Medical City · SAUniversity of Jordan · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeVaccination is a cost-efficient intervention to slow the spread of the coronavirus disease 2019 (COVID-19) pandemic. This study aims to assess the population's willingness to take the COVID-19 vaccine in Jordan and investigate potential determinants of their acceptance. MATERIALS AND

methodsThis study used an online survey distributed in November 2020, before introducing the vaccine, with items investigating socio-demographic characteristics, seasonal flu vaccination history, COVID-19 vaccine acceptance once available, and factors affecting their decision-making. Also, "COVID-19 risk perception" and beliefs toward COVID-19 vaccine benefits and barriers were assessed.

resultsA total of 2,208 participants completed the survey with a participation rate of 13.1%. The mean±standard deviation age was 33.2±13.5, and 55.7% were females. Study participants were almost equally distributed between willingness, unwillingness, and indecision to take the COVID-19 vaccine (30.4%, 36.4%, and 31.5%, respectively). Younger adults, males, and those who were not married, do not have children, have a bachelor or higher education, employees or being students, healthcare workers, and those who reported receiving flu vaccine had higher rates of COVID-19 vaccine acceptance compared to their counterparts (p<0.001 for each category). COVID-19 risk perception, and perceived vaccine benefits, and barriers were significant predictors of intention. Among those undecided or unwilling to take the COVID-19 vaccine, its safety and side effects were the most common concerns.

conclusionThe low rate of COVID-19 vaccine acceptance in a developing country is alarming, and a significant proportion are indecisive. Interventions to elevate vaccine acceptance by addressing its safety and efficacy and targeting vulnerable groups are recommended.

Indexed as

AcceptanceBarriersBenefitsCoronavirusCOVID-19Developing countryJordanRisk perceptionVaccine

Identifiers

PMID34222130
PMCPMC8217585
OpenAlexW3176672689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.